New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation

E-ISSN： 1875-6212|5|3|211-219

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.5, Iss.3, 2007-07, pp. : 211-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on Pharmacologic Approaches to Prevent Thromboembolism in Atrial Fibrillation: Are Thrombin and Factor Xa Inhibitors the Ultimate Answer?

Current Vascular Pharmacology, Vol. 9, Iss. 3, 2011-05 ,pp. : 350-357

Bentham Science Publishers

Access to resources Recommend Favorite

Atrial Fibrillation in Patients Undergoing Surgical Revascularization: An Update on Pharmacologic Prophylaxis

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 4, 2012-12 ,pp. : 325-338

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Pharmacologic Prophylaxis of Atrial Fibrillation in Patients Undergoing Surgical Revascularization

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 7, Iss. 2, 2009-04 ,pp. : 137-146

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic Relevance of K⁺Channel Remodeling in Atrial Fibrillation

By van Wagoner D.R.

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 10, 2000-10 ,pp. : 1763-1766

Academic Press

Access to resources Recommend Favorite

Is Atrial Fibrillation a Prognosticator in Acute Pulmonary Thromboembolism?

Medical Principles and Practice, Vol. 19, Iss. 2, 2010-02 ,pp. : 166-166

Karger

Access to resources Recommend Favorite